Funder
National Natural Science Foundation of China
Reference34 articles.
1. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial;Kang;Lancet,2017
2. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N. Engl. J. Med.,2006
3. Hallmarks of cancer: the next generation;Hanahan;Cell,2011
4. On the origin of cancer cells;Warburg;Science,1956
5. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate;Ward;Cancer Cell,2012
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献